Atlas Trials

Pre-approval Expanded Access of Retatrutide (LY3437943)

Clinical trial NCT07629401 · AVAILABLE

Trial details

NCT number
NCT07629401
Sponsor
Eli Lilly and Company
Status
AVAILABLE
Study type
EXPANDED_ACCESS
ObesityObesity-related Complications

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.